Rahlfs Capital LLC Invests $266,000 in CVS Health Co. (NYSE:CVS)

Rahlfs Capital LLC acquired a new stake in shares of CVS Health Co. (NYSE:CVS) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,930 shares of the pharmacy operator’s stock, valued at approximately $266,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Arete Wealth Advisors LLC bought a new position in CVS Health in the 3rd quarter worth about $1,369,000. Janus Henderson Group PLC increased its holdings in shares of CVS Health by 370.6% in the 3rd quarter. Janus Henderson Group PLC now owns 760,903 shares of the pharmacy operator’s stock worth $47,825,000 after buying an additional 599,200 shares during the last quarter. Jacobs Levy Equity Management Inc. purchased a new stake in shares of CVS Health during the 3rd quarter valued at $7,233,000. Morse Asset Management Inc bought a new stake in shares of CVS Health during the 3rd quarter worth $409,000. Finally, Royal London Asset Management Ltd. grew its position in CVS Health by 4.1% in the third quarter. Royal London Asset Management Ltd. now owns 520,107 shares of the pharmacy operator’s stock worth $32,704,000 after acquiring an additional 20,679 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In related news, SVP James David Clark sold 7,513 shares of the firm’s stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael F. Mahoney purchased 30,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.24% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of several recent research reports. Barclays increased their price objective on CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a research report on Thursday, February 13th. Leerink Partners upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $55.00 to $75.00 in a report on Thursday, February 13th. Wells Fargo & Company increased their target price on shares of CVS Health from $68.00 to $73.00 and gave the company an “overweight” rating in a report on Thursday, February 13th. JPMorgan Chase & Co. raised their price objective on CVS Health from $80.00 to $81.00 and gave the company an “overweight” rating in a research note on Tuesday, February 18th. Finally, Evercore ISI increased their target price on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $70.39.

CVS Health Stock Down 5.9 %

NYSE CVS opened at $63.54 on Friday. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $75.12. The stock’s 50 day moving average is $63.47 and its 200 day moving average is $58.01. The stock has a market cap of $80.11 billion, a PE ratio of 17.36, a P/E/G ratio of 0.98 and a beta of 0.54.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Research analysts predict that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.19%. The ex-dividend date is Tuesday, April 22nd. CVS Health’s payout ratio is 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.